Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M113Revenue (TTM) $M22.9Net Margin (%)-56.5Altman Z-Score-56.0
Enterprise Value $M175EPS (TTM) $-0.1Operating Margin %-10.4Piotroski F-Score5
P/E(ttm)--Beneish M-Score-7.0Pre-tax Margin (%)-61.7Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.1Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %-24.6Current Ratio0.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-100.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M156ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NAVBKeeley Asset Management Corp 2015-12-31 Sold Out $1.33 - $2.37
($1.72)
$ 0.73-58%Sold Out0
NAVBKeeley Asset Management Corp 2015-06-30 Buy $1.24 - $1.67
($1.45)
$ 0.73-50%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NAVB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-12-01Sell12,500$1.5-51.33view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-11-02Sell12,500$1.98-63.13view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-10-01Sell12,500$2.27-67.84view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-09-01Sell12,500$1.88-61.17view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-08-03Sell12,500$1.71-57.31view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.24-41.13view
Troup Gordon ADirector 2015-05-29Buy10,000$1.31-44.27view
FORD BRENDAN ADirector 2015-05-21Buy20,000$1.31-44.27view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.33-45.11view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.58-53.8view

Quarterly/Annual Reports about NAVB:

News about NAVB:

Articles On GuruFocus.com
Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 

More From Other Websites
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 30 2016
Edited Transcript of NAVB earnings conference call or presentation 3-Nov-16 12:30pm GMT Nov 28 2016
ETFs with exposure to Navidea Biopharmaceuticals, Inc. : November 28, 2016 Nov 28 2016
Navidea Signs Asset Purchase Agreement with Cardinal Health Nov 23 2016
Navidea Signs Asset Purchase Agreement with Cardinal Health Nov 23 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Financials Nov 17 2016
Navidea Biopharmace21860helestones Nov 14 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016
ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : November 8, 2016 Nov 08 2016
Navidea Biopharmaceuticals, Inc. :NAVB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7,... Nov 07 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 03 2016
Navidea Reports 2016 Third Quarter Financial Results Nov 03 2016
Q3 2016 Navidea Biopharmaceuticals Inc Earnings Release - Before Market Open Nov 03 2016
Navidea Reports 2016 Third Quarter Financial Results Nov 03 2016
Navidea Biopharmaceuticals to Announce Third Quarter 2016 Financial Results on November 3, 2016 Oct 27 2016
Navidea Biopharmaceuticals to Announce Third Quarter 2016 Financial Results on November 3, 2016 Oct 27 2016
ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : October 6, 2016 Oct 06 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Sep 27 2016
Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer Sep 26 2016
Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer Sep 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)